BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

17 related articles for article (PubMed ID: 25796944)

  • 1. Transient red blood cell agglutination after Magrolimab administration in acute myeloid leukemia.
    Leveque A; Rolland D; Ledoux MP; Simand C; Eischen A; Mayeur-Rousse C
    Int J Lab Hematol; 2024 Aug; 46(4):591-592. PubMed ID: 38366740
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia.
    Koter M; Franiak I; Broncel M; Chojnowska-Jezierska J
    Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamics of microrheologic properties of erythrocytes in patients with arterial hypertension and dyslipidemia treated with atorvastatin].
    Medvedev IN; Skoriatina IA
    Klin Med (Mosk); 2012; 90(6):42-5. PubMed ID: 22997720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of atorvastatin on hemorheological parameters in patients with arterial hypertension with dyslipidemia].
    Abrashkina ED; Shaalali N; Pakhrova OA; Shutemova EA; Nazarova OA
    Kardiologiia; 2010; 50(5):25-8. PubMed ID: 20831044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The comparison in vitro the effects of pravastatin and quercetin on the selected structural parameters of membrane erythrocytes from patients with hypercholesterolemia].
    Broncel M; Franiak I; Koter-Michalak M; Duchnowicz P; Chojnowska-Jezierska J
    Pol Merkur Lekarski; 2007 Feb; 22(128):112-6. PubMed ID: 17598654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk reductions for cardiovascular disease with pravastatin treatment by dyslipidemia phenotype: a post hoc analysis of the MEGA Study.
    Nishiwaki M; Ikewaki K; Ayaori M; Mizuno K; Ohashi Y; Ohsuzu F; Ishikawa T; Nakamura H;
    J Cardiol; 2013 Mar; 61(3):196-200. PubMed ID: 23265677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Erythrocyte aggregation in patients with arterial hypertension and dyslipidemia treated with pravastatin].
    Medvedev IN; Skoriatina IA
    Klin Med (Mosk); 2014; 92(11):34-8. PubMed ID: 25796944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte aggregation and metabolic syndrome.
    Gyawali P; Richards RS; Hughes DL; Tinley P
    Clin Hemorheol Microcirc; 2014; 57(1):73-83. PubMed ID: 24192695
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.